Literature DB >> 7590185

Variable sequences in a mosaic-like domain of meningococcal tbp2 encode immunoreactive epitopes.

B Rokbi1, G Maitre-Wilmotte, V Mazarin, L Fourrichon, L Lissolo, M J Quentin-Millet.   

Abstract

Transferrin-binding proteins from Neisseria meningitidis vary among different isolates. We have identified and studied a hypervariable region adjacent to the carboxyl-end of the transferrin-binding domain of the Tbp2 molecule. The tbp2 genes from six strains of N. meningitidis were cloned and sequenced in this particular region. Sequence analysis of these regions along with five other sequences available from pathogenic Neisseria showed a common organisation of seven highly variable nucleotide stretches interspersed with six conserved nucleotide stretches. The variable regions correlated with the location of immunoreactive epitopes in polyclonal antisera raised to transferrin-binding proteins identified by peptide pin technology. Sequence analysis suggested a mosaic-like organisation of the tbp2 genes. Taken together, these data suggest that the antigenic variation in this part of the protein may result from a strong host immune pressure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590185     DOI: 10.1016/0378-1097(95)00326-z

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  11 in total

1.  Characterization of the diversity and the transferrin-binding domain of gonococcal transferrin-binding protein 2.

Authors:  C N Cornelissen; J E Anderson; P F Sparling
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

2.  Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains.

Authors:  B Rokbi; M Mignon; G Maitre-Wilmotte; L Lissolo; B Danve; D A Caugant; M J Quentin-Millet
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

3.  Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex.

Authors:  B Rokbi; M Mignon; D A Caugant; M J Quentin-Millet
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

4.  Evidence for a common gene pool and frequent recombinational exchange of the tbpBA operon in Mannheimia haemolytica, Mannheimia glucosida and Bibersteinia trehalosi.

Authors:  Inkyoung Lee; Robert L Davies
Journal:  Microbiology (Reading)       Date:  2010-09-30       Impact factor: 2.777

5.  Identification of transferrin-binding domains in TbpB expressed by Neisseria gonorrhoeae.

Authors:  Amanda J DeRocco; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

6.  Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection.

Authors:  D West; K Reddin; M Matheson; R Heath; S Funnell; M Hudson; A Robinson; A Gorringe
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

7.  Identification of human transferrin-binding sites within meningococcal transferrin-binding protein B.

Authors:  G Renauld-Mongénie; D Poncet; L von Olleschik-Elbheim; T Cournez; M Mignon; M A Schmidt; M J Quentin-Millet
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

8.  The modular architecture of meningococcal factor H-binding protein.

Authors:  Peter T Beernink; Dan M Granoff
Journal:  Microbiology (Reading)       Date:  2009-07-02       Impact factor: 2.777

9.  Description of an unusual Neisseria meningitidis isolate containing and expressing Neisseria gonorrhoeae-Specific 16S rRNA gene sequences.

Authors:  Marion Walcher; Rhonda Skvoretz; Megan Montgomery-Fullerton; Vivian Jonas; Steve Brentano
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

10.  Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes.

Authors:  R P Du; Q Wang; Y P Yang; A B Schryvers; P Chong; M H Klein; S M Loosmore
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.